Mostrar el registro sencillo del ítem

dc.creatorStein, Dan J.es_ES
dc.creatorKazdin, Alan E.es_ES
dc.creatorMunthali, Richard J.es_ES
dc.creatorHwang, Irvinges_ES
dc.creatorHarris, Meredith G.es_ES
dc.creatorAlonso, Jordies_ES
dc.creatorAndrade, Laura Helenaes_ES
dc.creatorBrufaerts, Ronnyes_ES
dc.creatorCardoso, Graçaes_ES
dc.creatorChardoul, Stephaniees_ES
dc.creatorGirolamo, Giovanni dees_ES
dc.creatorFlorescu, Silviaes_ES
dc.creatorGureje, Oyees_ES
dc.creatorHaro, Josep Mariaes_ES
dc.creatorKaram, Aimee N.es_ES
dc.creatorKaram, Elie G.es_ES
dc.creatorKovess-Masfety, Vivianees_ES
dc.creatorLee, Singes_ES
dc.creatorMedina-Mora, Maria Elenaes_ES
dc.creatorNavarro-Mateu, Fernandoes_ES
dc.creatorPosada-Villa, Josées_ES
dc.creatorStagnaro, Juan Carloses_ES
dc.creatorHave, Margreet tenes_ES
dc.creatorSampson, Nancy A.es_ES
dc.creatorKessler, Ronald C.es_ES
dc.creatorVigo, Daniel V.es_ES
dc.creatorWHO World Mental Health Survey Collaboratorses_ES
dc.creatorAguilar-Gaxiola, Sergioes_ES
dc.creatorAl-Hamzawi, Alies_ES
dc.creatorAlonso, Jordies_ES
dc.creatorAltwaijri, Yasmin A.es_ES
dc.creatorAndrade, Laura Helenaes_ES
dc.creatorAtwoli, Lukoyees_ES
dc.creatorBenjet, Corinaes_ES
dc.creatorBorges, Guilhermees_ES
dc.creatorBromet, Evelyn J.es_ES
dc.creatorBruffaerts, Ronnyes_ES
dc.creatorBunting, Brendanes_ES
dc.creatorCaldas-de-Almeida, Jose Migueles_ES
dc.creatorCardoso, Graçaes_ES
dc.creatorChardoul, Stephaniees_ES
dc.creatorChatterji, Somnathes_ES
dc.creatorCia, Alfredo H.es_ES
dc.creatorDegenhardt, Louisaes_ES
dc.creatorDemyttenaere, Koenes_ES
dc.creatorFlorescu, Silviaes_ES
dc.creatorGirolamo, Giovannies_ES
dc.creatorGureje, Oyees_ES
dc.creatorHaro, Josep Mariaes_ES
dc.creatorHarris, Meredith G.es_ES
dc.creatorHinkov, Hristoes_ES
dc.creatorHu, Chi-Yies_ES
dc.creatorJonge, Peter dees_ES
dc.creatorKaram, Aimee Nasseres_ES
dc.creatorKaram, Elie G.es_ES
dc.creatorKaram, Georgeses_ES
dc.creatorKawakami, Noritoes_ES
dc.creatorKessler, Ronald C.es_ES
dc.creatorKiejna, Andrzejes_ES
dc.creatorKovess-Masfety, Vivianees_ES
dc.creatorLee, Singes_ES
dc.creatorLepine, Jean-Pierrees_ES
dc.creatorMcGrath, John J.es_ES
dc.creatorMoskalewicz, Jacekes_ES
dc.creatorNavarro-Mateu, Fernandoes_ES
dc.creatorPiazza, Marinaes_ES
dc.creatorPosada-Villa, Josees_ES
dc.creatorScott, Kate M.es_ES
dc.creatorSlade, Times_ES
dc.creatorStagnaro, Juan Carloses_ES
dc.creatorStein, Dan J.es_ES
dc.creatorHave, Margreet tenes_ES
dc.creatorTorres, Yolandaes_ES
dc.creatorViana, Maria Carmenes_ES
dc.creatorVigo, Daniel V.es_ES
dc.creatorWhiteford, Harveyes_ES
dc.creatorWilliams, David R.es_ES
dc.creatorWojtyniak, Bogdanes_ES
dc.date2023
dc.date.accessioned2025-03-24T20:25:25Z
dc.date.available2025-03-24T20:25:25Z
dc.date.issued2023
dc.identifierJC33DIEP23es_ES
dc.identifier.urihttp://repositorio.inprf.gob.mx/handle/123456789/8266
dc.identifier.urihttps://doi.org/10.1186/s12888-023-04605-2
dc.descriptionBackground: Posttraumatic stress disorder (PTSD) is associated with significant morbidity, but efficacious pharmacotherapy and psychotherapy are available. Data from the World Mental Health Surveys were used to investigate extent and predictors of treatment coverage for PTSD in high-income countries (HICs) as well as in low- and middle-income countries (LMICs). Methods: Seventeen surveys were conducted across 15 countries (9 HICs, 6 LMICs) by the World Health Organization (WHO) World Mental Health Surveys. Of 35,012 respondents, 914 met DSM-IV criteria for 12-month PTSD. Components of treatment coverage analyzed were: (a) any mental health service utilization; (b) adequate pharmacotherapy; (c) adequate psychotherapy; and (d) effective treatment coverage. Regression models investigated predictors of treatment coverage. Results: 12-month PTSD prevalence in trauma exposed individuals was 1.49 (S.E., 0.08). A total of 43.0% (S.E., 2.2) received any mental health services, with fewer receiving adequate pharmacotherapy (13.5%), adequate psychotherapy (17.2%), or effective treatment coverage (14.4%), and with all components of treatment coverage lower in LMICs than HICs. In a multivariable model having insurance (OR = 2.31, 95 CI 1.17, 4.57) and severity of symptoms (OR = .35, 95% CI 0.18, 0.70) were predictive of effective treatment coverage. Conclusion: There is a clear need to improve pharmacotherapy and psychotherapy coverage for PTSD, particularly in those with mild symptoms, and especially in LMICs. Universal health care insurance can be expected to increase effective treatment coverage and therefore improve outcomes.es_ES
dc.formatPDFes_ES
dc.language.isoenges_ES
dc.publisherBioMed Centrales_ES
dc.relation23(1):226
dc.rightsAcceso Cerradoes_ES
dc.titleDeterminants of effective treatment coverage for posttraumatic stress disorder: findings from the World Mental Health Surveyses_ES
dc.typeArtículoes_ES
dc.contributor.affiliationDepartment of Psychiatry & Mental Health and South African Medical Council Research Unit on Risk and Resilience in Mental Disorders, University of Cape Town and Groote Schuur Hospital, Cape Town, South Africa
dc.contributor.emaildan.stein@uct.ac.za (Dan J. Stein)
dc.relation.jnabreviadoBMC PSYCHIATRY
dc.relation.journalBMC Psychiatry
dc.identifier.placeInglaterra
dc.date.published2023
dc.identifier.organizacionInstituto Nacional de Psiquiatría Ramón de la Fuente Muñiz
dc.identifier.eissn1471-244X
dc.identifier.doi10.1186/s12888-023-04605-2
dc.subject.kwPosttraumatic stress disorder
dc.subject.kwContact coverage
dc.subject.kwEfective treatment coverage
dc.subject.kwInsurance


Ficheros en el ítem

FicherosTamañoFormatoVer

No hay ficheros asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem